Northwest Biotherapeutics

Northwest Biotherapeutics

Northwest Biotherapeutics

NW Bio is a biotech company developing immune therapies (DCVax®) to treat a broad range of cancers including brain, prostate & ovarian.
Founded
1998
Raised
$123.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$10,000,000
Post-IPO debt - 2016
$40,000,000
Post-IPO equity - 2015
Team Size
1–10
Employees
The Motley Fool

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today --

Stock markets